Literature DB >> 1983816

Geographic variation of inflammatory bowel disease within the United States.

A Sonnenberg1, D J McCarty, S J Jacobsen.   

Abstract

One approach to learn about possible environmental risks in inflammatory bowel disease relates to studying its geographic pattern of occurrence. The geographic variation of inflammatory bowel disease within the United States was analyzed using the accumulated 17.5 million hospital discharges of all U.S. Medicare beneficiaries during two consecutive years. To validate the geographic pattern shown by the Medicare data, hospitalization was compared with mortality from inflammatory bowel disease among different states. Mortality and hospitalization statistics both suggested that the occurrence of inflammatory bowel disease was determined by environmental factors that had a marked geographic variation within the United States. Both Crohn's disease and ulcerative colitis appeared to be more frequent in northern parts of the United States than in southern and in urban more than rural parts. These trends were observed for men and women and for blacks and whites alike. Similar geographic patterns of Crohn's disease and ulcerative colitis suggested the influence of one or more identical risk factors for both diseases.

Entities:  

Mesh:

Year:  1991        PMID: 1983816     DOI: 10.1016/0016-5085(91)90594-b

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  49 in total

1.  Helminths and harmony.

Authors:  J V Weinstock; R Summers; D E Elliott
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

2.  Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families.

Authors:  Turgut Tukel; Adel Shalata; Daniel Present; Daniel Rachmilewitz; Lloyd Mayer; Deniera Grant; Neil Risch; Robert J Desnick
Journal:  Am J Hum Genet       Date:  2004-03-05       Impact factor: 11.025

3.  Gastroduodenal Crohn's disease and pancreatitis.

Authors:  Casper G Noomen; Roelof A Veenendaal; Hein W Verspaget
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-07

Review 4.  Will worms really cure Crohn's disease?

Authors:  G L Radford-Smith
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 5.  Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Authors:  Millie D Long; Susan Hutfless; Michael D Kappelman; Hamed Khalili; Gilaad G Kaplan; Charles N Bernstein; Jean Frederic Colombel; Corinne Gower-Rousseau; Lisa Herrinton; Fernando Velayos; Edward V Loftus; Geoffrey C Nguyen; Ashwin N Ananthakrishnan; Amnon Sonnenberg; Andrew Chan; Robert S Sandler; Ashish Atreja; Samir A Shah; Kenneth J Rothman; Neal S Leleiko; Renee Bright; Paolo Boffetta; Kelly D Myers; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

6.  Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state.

Authors:  Sif Hansdottir; Martha M Monick; Nina Lovan; Linda Powers; Alicia Gerke; Gary W Hunninghake
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

Review 7.  Restorative procedures in colonic crohn disease.

Authors:  Sean T Martin; Jon D Vogel
Journal:  Clin Colon Rectal Surg       Date:  2013-06

8.  Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis.

Authors:  T Hagenau; R Vest; T N Gissel; C S Poulsen; M Erlandsen; L Mosekilde; P Vestergaard
Journal:  Osteoporos Int       Date:  2008-05-06       Impact factor: 4.507

Review 9.  Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children.

Authors:  Theresa A Mikhailov; Sylvia E Furner
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

Review 10.  Inflammatory bowel disease: genetic and epidemiologic considerations.

Authors:  Judy H Cho
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.